II-VI Q1 EPS $0.87 Beats $0.83 Estimate, Sales $795.00M Miss $808.60M Estimate
Today, 3:38 PM
II-VI (NASDAQ:IIVI) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.83 by 4.82 percent. This is a 3.57 percent increase over earnings of $0.84 per share from the same period
II-VI Q1 EPS $0.87 Beats $0.83 Estimate, Sales $795.00M Miss $808.60M Estimate
Today, 3:38 PM
II-VI (NASDAQ:IIVI) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.83 by 4.82 percent. This is a 3.57 percent increase over earnings of $0.84 per share from the same period
Earnings Scheduled For November 9, 2021
Today, 3:38 PM
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
II-VI Incorporated Awarded IARPA Development Contract For High-Energy Rechargeable Lithium Batteries In Partnership With EaglePicher Technologies; Terms Not Disclosed
Today, 3:38 PM
II‐VI Incorporated (NASDAQ:IIVI), a leader in engineered materials, today announced that it was awarded a multimillion-dollar development contract for high-energy rechargeable lithium batteries by the U.S. Intelligence
Which Apple Chip Suppliers Will Face The Biggest Impact From iPhone Production Cuts?
Today, 3:38 PM
Apple Inc (NASDAQ: AAPL) is reportedly looking to cut its iPhone production forecast for 2021 by 10 million due to supply chain issues.
How Analysts View II-VI’s Acquisition Of Coherent?
Today, 3:38 PM
Barclays analyst Tom O'Malley downgraded II-VI Inc (NASDAQ: IIVI) to Underweight from Equal Weight with a price target of $56, down from $65.
Barclays Downgrades II-VI to Underweight, Lowers Price Target to $56
Today, 3:38 PM
Barclays analyst Tom O'Malley downgrades II-VI (NASDAQ:IIVI) from Equal-Weight to Underweight and lowers the price target from $65 to $56.
Benchmark Maintains Buy on II-VI, Lowers Price Target to $90
Today, 3:38 PM
Benchmark analyst Mark Miller maintains II-VI (NASDAQ:IIVI) with a Buy and lowers the price target from $105 to $90.